Accela Pharmaceuticals Private Limited

Develops and manufactures pharmaceutical products and offers consultancy services.

2010 | Pune, Maharashtra (India) | Active
Last Updated:

Accela Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 14 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth -31.03%
  • Profit Growth -34.57%
  • Ebitda -31.63%
  • Net Worth 16.13%
  • Total Assets -28.73%

About Accela Pharmaceuticals

Accela Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 July 2010 and has a history of 14 years and eight months. Its registered office is in Pune, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.

Dinesh Bothra and Pragati Bothara serve as directors at the Company.

Company Details

  • Location

    Pune, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232PN2010PTC136759

  • Company No.

    136759

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    05 Jul 2010

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Pune

Industry

Pharma

Who are the key members and board of directors at Accela Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Dinesh Bothra Country flag representing In Director 05-Jul-2010Current
Pragati Bothara Country flag representing In Director 30-Mar-2022Current

Financial Performance of Accela Pharmaceuticals.

Accela Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.03% decrease. The company also saw a substantial fall in profitability, with a 34.57% decrease in profit. The company's net worth Soared by an impressive increase of 16.13%.

Accela Pharmaceuticals revenue growth over time
Accela Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-31.03%
Revenue from Operations
-31.03%
Total Assets
-28.73%
Profit or Loss
-34.57%
Net Worth
16.13%
EBITDA
-31.63%

What is the Ownership and Shareholding Structure of Accela Pharmaceuticals?

In 2023, Accela Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Accela Pharmaceuticals?

Unlock and access historical data on people associated with Accela Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Accela Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Accela Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accela Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Accela Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Accela Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Accela Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune.

  • Director Appointment

    Pragati Dinesh Bothara was appointed as a Director was appointed as a Director on 30 Mar 2022 & has been associated with this company since 2 years 11 months .

  • Director Appointment

    Dinesh Keshari Chand Bothra was appointed as a Director was appointed as a Director on 05 Jul 2010 & has been associated with this company since 14 years 8 months .

  • Company Incorporation

    Accela Pharmaceuticals Private Limited was registered on 05 Jul 2010 with Roc Pune & aged 14 years 8 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Accela Pharmaceuticals Private Limited?

    Accela Pharmaceuticals Private Limited was incorporated on 05 Jul 2010.

  • What is authorized share capital and paid-up capital of Accela Pharmaceuticals Private Limited?

    The authorized share capital of Accela Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.15 M.

  • Who are the current board members & directors of Accela Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Accela Pharmaceuticals Private Limited.

    • Dinesh Keshari Chand Bothra
    • Pragati Dinesh Bothara

  • What is the registered address of Accela Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Accela Pharmaceuticals Private Limited is S No. 118 To 124 Plot No 98 National Soc Aundh, India, Pune, Maharashtra, 411021.

  • What is the corporate identification number (CIN) and company number of Accela Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Accela Pharmaceuticals Private Limited is U24232PN2010PTC136759 and the company number is 136759 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Accela Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Accela Pharmaceuticals Private Limited has fallen by -31.03%.

  • What change has been observed in the net worth of Accela Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Accela Pharmaceuticals Private Limited has experienced an upsurge of 16.13%.

  • When was the last Balance Sheet of Accela Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Accela Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed